Can Photobiomodulation Improve Balance and Cognition in Individuals Over 60: a Pilot Feasibility Placebo Randomized Controlled Trial.

November 21, 2025 updated by: Jonathan Sinclair, University of Central Lancashire

As people age, changes in balance and memory can make daily life more difficult and increase the risk of falls. Falls are one of the main causes of injury, hospitalization and loss of independence in older adults, while even mild declines in memory and concentration can reduce confidence, social participation and overall quality of life. Therefore, safe, affordable, and practical ways to help older adults remain steady on their feet and mentally sharp are urgently needed.

The aim of this project is therefore to conduct a pilot feasibility randomized controlled trial to examine whether regular home-based photobiomodulation can improve balance and cognitive function in adults aged over 60. If successful, this research could help shape future strategies for preventing falls, enhancing wellbeing and maintaining independence in older people.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Lancashire
      • Preston, Lancashire, United Kingdom, PR4 0PE
        • Recruiting
        • University of Central Lancashire
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Aged from 60-80 years
  • Ability to complete written questionnaires independently
  • Able to provide informed consent

Exclusion Criteria:

  • Current or past history of head injury
  • Use of medications acting on the central nervous system
  • Active skin conditions on the forehead or scalp
  • Ongoing brain stimulation therapy
  • History of migraines
  • Sensitive skin, allergies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Sham photobiomodulation

8-weeks sham photobiomodulation.

The sham device will follow the same protocol but without active light emission.

The sham device will follow the same protocol but without active light emission.
Experimental: Photobiomodulation

8-weeks photobiomodulation

Twenty-four-minute photobiomodulation stimulation (twelve minutes at 670 nm followed by twelve minutes at 810 nm). Three times per week for 8-weeks.

8-weeks photobiomodulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
n-1-back (deviation)
Time Frame: Baseline
The n-1-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-1 trials earlier.
Baseline
n-1-back (deviation)
Time Frame: 1 hour
The n-1-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-1 trials earlier.
1 hour
n-1-back (deviation)
Time Frame: 8-weeks
The n-1-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-1 trials earlier.
8-weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Beck Depression Inventory
Time Frame: Baseline
Psychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible.
Baseline
n-2-back (deviation)
Time Frame: Baseline
The n-2-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-2 trials earlier.
Baseline
n-2-back (deviation)
Time Frame: 1 hour
The n-2-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-2 trials earlier.
1 hour
n-2-back (deviation)
Time Frame: 8-weeks
The n-2-back (deviation) task is a working memory test where participants respond when the current stimulus differs from the one presented n-2 trials earlier.
8-weeks
n-1-back (post-deviation)
Time Frame: Baseline
The n-1-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-1 trials earlier.
Baseline
n-1-back (post-deviation)
Time Frame: 1 hour
The n-1-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-1 trials earlier.
1 hour
n-1-back (post-deviation)
Time Frame: 8-weeks
The n-1-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-1 trials earlier.
8-weeks
n-2-back (post-deviation)
Time Frame: Baseline
The n-2-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-2 trials earlier.
Baseline
n-2-back (post-deviation)
Time Frame: 1 hour
The n-2-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-2 trials earlier.
1 hour
n-2-back (post-deviation)
Time Frame: 8-weeks
The n-2-back (post-deviation) task assesses working memory performance on the trial immediately following a deviation from the stimulus presented n-2 trials earlier.
8-weeks
n-1-back (post-target)
Time Frame: Baseline
The n-1-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-1 trials earlier.
Baseline
n-1-back (post-target)
Time Frame: 1 hour
The n-1-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-1 trials earlier.
1 hour
n-1-back (post-target)
Time Frame: 8-weeks
The n-1-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-1 trials earlier.
8-weeks
n-2-back (post-target)
Time Frame: Baseline
he n-2-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-2 trials earlier.
Baseline
n-2-back (post-target)
Time Frame: 1 hour
he n-2-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-2 trials earlier.
1 hour
n-2-back (post-target)
Time Frame: 8-weeks
he n-2-back (post-target) task assesses working memory performance on the trial immediately following a target that matched the stimulus presented n-2 trials earlier.
8-weeks
n-1-back (load)
Time Frame: Baseline
The n-1-back (load) condition measures working memory performance under the cognitive demand of tracking stimuli 1 trial back.
Baseline
n-1-back (load)
Time Frame: 1 hour
The n-1-back (load) condition measures working memory performance under the cognitive demand of tracking stimuli 1 trial back.
1 hour
n-1-back (load)
Time Frame: 8-weeks
The n-1-back (load) condition measures working memory performance under the cognitive demand of tracking stimuli 1 trial back.
8-weeks
n-2-back (post-load)
Time Frame: Baseline
The n-2-back (post-load) condition assesses working memory performance on the trial immediately following a high cognitive load in the n-2-back task.
Baseline
n-2-back (post-load)
Time Frame: 1 hour
The n-2-back (post-load) condition assesses working memory performance on the trial immediately following a high cognitive load in the n-2-back task.
1 hour
n-2-back (post-load)
Time Frame: 8-weeks
The n-2-back (post-load) condition assesses working memory performance on the trial immediately following a high cognitive load in the n-2-back task.
8-weeks
Coop-Wonka chart
Time Frame: Baseline
The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring system for each thus the chart has a maximum score of 30 which indicates the lowest possible psychological Wellbeing.
Baseline
Coop-Wonka chart
Time Frame: 1 hour
The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring system for each thus the chart has a maximum score of 30 which indicates the lowest possible psychological Wellbeing.
1 hour
Coop-Wonka chart
Time Frame: 8-weeks
The Coop-Wonka chart is a six item questionnaire with a 1-5 scoring system for each thus the chart has a maximum score of 30 which indicates the lowest possible psychological Wellbeing.
8-weeks
Beck Depression Inventory
Time Frame: 1 hour
Psychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible.
1 hour
Beck Depression Inventory
Time Frame: 8-weeks
Psychological wellbeing - the Beck Depression Inventory is a 21 questionnaire with questions that range in scoring from 0-3, thus the maximum score is 63 which is the highest depression score possible.
8-weeks
Pittsburgh Sleep Quality Index
Time Frame: Baseline
The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components. Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality.
Baseline
Pittsburgh Sleep Quality Index
Time Frame: 1 hour
The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components. Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality.
1 hour
Pittsburgh Sleep Quality Index
Time Frame: 8-weeks
The Pittsburgh Sleep Quality index, is a questionnaire that consists of 19 self-rated questions, grouped into 7 components. Each component is scored separately, weighted equally on a 0 - 3 scale and the scores of the 7 components are then added to give a global score, which has a range of 0 - 21 with higher scores indicating worse sleep quality.
8-weeks
State Trait Anxiety Inventory
Time Frame: Baseline
The state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety.
Baseline
State Trait Anxiety Inventory
Time Frame: 1 hour
The state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety.
1 hour
State Trait Anxiety Inventory
Time Frame: 8-weeks
The state trait anxiety inventory is a 40 item questionnaire with each question having a 1-4 score system, thus the maximum score is 80 which indicates the highest level of anxiety.
8-weeks
Insomnia Severity Index
Time Frame: Baseline
The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia. The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28.
Baseline
Insomnia Severity Index
Time Frame: 1 hour
The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia. The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28.
1 hour
Insomnia Severity Index
Time Frame: 8-weeks
The Insomnia Severity Index is a brief instrument designed to assess the severity of both nighttime and daytime components of insomnia. The Insomnia Severity Index is a 7-item self-report questionnaire yielding a total score ranging from 0 to 28.
8-weeks
Epworth Sleepiness Scale
Time Frame: Baseline
The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24.
Baseline
Epworth Sleepiness Scale
Time Frame: 1 hour
The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24.
1 hour
Epworth Sleepiness Scale
Time Frame: 8-weeks
The Epworth Sleepiness Scale is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3) with a maximum score of 24.
8-weeks
Everyday Memory Errors Questionnaire
Time Frame: Baseline
The Everyday Memory Errors Questionnaire is a brief self-report instrument designed to assess the frequency of memory lapses in daily life. It consists of multiple items that yield a total score reflecting the extent of everyday memory difficulties.
Baseline
Everyday Memory Errors Questionnaire
Time Frame: 1 hour
The Everyday Memory Errors Questionnaire is a brief self-report instrument designed to assess the frequency of memory lapses in daily life. It consists of multiple items that yield a total score reflecting the extent of everyday memory difficulties.
1 hour
Everyday Memory Errors Questionnaire
Time Frame: 8-weeks
The Everyday Memory Errors Questionnaire is a brief self-report instrument designed to assess the frequency of memory lapses in daily life. It consists of multiple items that yield a total score reflecting the extent of everyday memory difficulties.
8-weeks
Falls Efficacy
Time Frame: Baseline
The Falls Efficacy Scale is a brief self-report instrument designed to assess confidence in performing daily activities without falling. It consists of multiple items that yield a total score reflecting fear of falling and perceived fall-related self-efficacy.
Baseline
Falls Efficacy
Time Frame: 1 hour
The Falls Efficacy Scale is a brief self-report instrument designed to assess confidence in performing daily activities without falling. It consists of multiple items that yield a total score reflecting fear of falling and perceived fall-related self-efficacy.
1 hour
Falls Efficacy
Time Frame: 8-weeks
The Falls Efficacy Scale is a brief self-report instrument designed to assess confidence in performing daily activities without falling. It consists of multiple items that yield a total score reflecting fear of falling and perceived fall-related self-efficacy.
8-weeks
Anterior-posterior balance
Time Frame: Baseline
The maximum anterior-posterior displacement of the centre of pressure during a two-minute balance task.
Baseline
Anterior-posterior balance
Time Frame: 1 hour
The maximum anterior-posterior displacement of the centre of pressure during a two-minute balance task.
1 hour
Anterior-posterior balance
Time Frame: 8-weeks
The maximum anterior-posterior displacement of the centre of pressure during a two-minute balance task.
8-weeks
Medio-lateral balance
Time Frame: Baseline
The maximum medio-lateral displacement of the centre of pressure during a two-minute balance task.
Baseline
Medio-lateral balance
Time Frame: 1 hour
The maximum medio-lateral displacement of the centre of pressure during a two-minute balance task.
1 hour
Medio-lateral balance
Time Frame: 8-weeks
The maximum medio-lateral displacement of the centre of pressure during a two-minute balance task.
8-weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2025

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

July 10, 2027

Study Registration Dates

First Submitted

November 21, 2025

First Submitted That Met QC Criteria

November 21, 2025

First Posted (Estimated)

December 3, 2025

Study Record Updates

Last Update Posted (Estimated)

December 3, 2025

Last Update Submitted That Met QC Criteria

November 21, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • PMB balance and cognition

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Age >60

Clinical Trials on Sham 8-weeks photobiomodulation

Subscribe